Garadacimab and csl112, page-7

  1. 7,862 Posts.
    lightbulb Created with Sketch. 2487
    Simplisticlly, 50 p/s that would imply NPAT contribution of 500m plus, perhaps eventually 1b

    I've guessed at 10% re-rate because part of the CSL112 value is already priced into the stock, along with the rest of the R^D pipeline. So if it fails, the stock will drop a fair chunk.

    Last edited by JoeGambler: 10/01/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$270.59
Change
2.670(1.00%)
Mkt cap ! $131.0B
Open High Low Value Volume
$268.49 $272.20 $268.22 $143.6M 531.0K

Buyers (Bids)

No. Vol. Price($)
7 2408 $270.59
 

Sellers (Offers)

Price($) Vol. No.
$271.18 10 1
View Market Depth
Last trade - 16.10pm 28/07/2025 (20 minute delay) ?
CSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.